158 related articles for article (PubMed ID: 23340241)
1. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.
Gershman B; Shui IM; Stampfer M; Platz EA; Gann PH; Sesso HL; DuPre N; Giovannucci E; Mucci LA
Eur Urol; 2014 Apr; 65(4):683-9. PubMed ID: 23340241
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
3. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
5. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
6. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
[TBL] [Abstract][Full Text] [Related]
7. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.
Graff RE; Meisner A; Ahearn TU; Fiorentino M; Loda M; Giovannucci EL; Mucci LA; Pettersson A
Br J Cancer; 2016 Apr; 114(8):939-44. PubMed ID: 26986253
[TBL] [Abstract][Full Text] [Related]
8. Pre-diagnostic sex hormone levels and survival among breast cancer patients.
Kensler KH; Eliassen AH; Rosner BA; Hankinson SE; Brown M; Tamimi RM
Breast Cancer Res Treat; 2019 Apr; 174(3):749-758. PubMed ID: 30604001
[TBL] [Abstract][Full Text] [Related]
9. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
10. Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
Xie SH; Ness-Jensen E; Langseth H; Gislefoss RE; Mattsson F; Lagergren J
Int J Cancer; 2021 Feb; 148(4):905-913. PubMed ID: 32895915
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
; Roddam AW; Allen NE; Appleby P; Key TJ
J Natl Cancer Inst; 2008 Feb; 100(3):170-83. PubMed ID: 18230794
[TBL] [Abstract][Full Text] [Related]
12. Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study.
Kenfield SA; DuPre N; Richman EL; Stampfer MJ; Chan JM; Giovannucci EL
Eur Urol; 2014 May; 65(5):887-94. PubMed ID: 23962747
[TBL] [Abstract][Full Text] [Related]
13. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
Ahn J; Schumacher FR; Berndt SI; Pfeiffer R; Albanes D; Andriole GL; Ardanaz E; Boeing H; Bueno-de-Mesquita B; Chanock SJ; Clavel-Chapelon F; Diver WR; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hoover RN; Kolonel LN; Kraft P; Ma J; Le Marchand L; Overvad K; Palli D; Stattin P; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Kaaks R; Hunter DJ; Hayes RB
Hum Mol Genet; 2009 Oct; 18(19):3749-57. PubMed ID: 19574343
[TBL] [Abstract][Full Text] [Related]
14. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract][Full Text] [Related]
15. Sex hormones and the risk of incident prostate cancer.
Daniels NA; Nielson CM; Hoffman AR; Bauer DC;
Urology; 2010 Nov; 76(5):1034-40. PubMed ID: 20451981
[TBL] [Abstract][Full Text] [Related]
16. The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.
Belledant A; Hovington H; Garcia L; Caron P; Brisson H; Villeneuve L; Simonyan D; Têtu B; Fradet Y; Lacombe L; Guillemette C; Lévesque E
Eur Urol; 2016 Apr; 69(4):601-609. PubMed ID: 26215610
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic serum hormones and the risk of prostate cancer.
Nomura A; Heilbrun LK; Stemmermann GN; Judd HL
Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644
[TBL] [Abstract][Full Text] [Related]
18. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
Schenk JM; Till C; Hsing AW; Stanczyk FZ; Gong Z; Neuhouser ML; Reichardt JK; Hoque AM; Figg WD; Goodman PJ; Tangen CM; Thompson IM
Cancer Causes Control; 2016 Feb; 27(2):175-82. PubMed ID: 26589415
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
Eaton NE; Reeves GK; Appleby PN; Key TJ
Br J Cancer; 1999 Jun; 80(7):930-4. PubMed ID: 10362098
[TBL] [Abstract][Full Text] [Related]
20. Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
Watts EL; Appleby PN; Albanes D; Black A; Chan JM; Chen C; Cirillo PM; Cohn BA; Cook MB; Donovan JL; Ferrucci L; Garland CF; Giles GG; Goodman PJ; Habel LA; Haiman CA; Holly JMP; Hoover RN; Kaaks R; Knekt P; Kolonel LN; Kubo T; Le Marchand L; Luostarinen T; MacInnis RJ; Mäenpää HO; Männistö S; Metter EJ; Milne RL; Nomura AMY; Oliver SE; Parsons JK; Peeters PH; Platz EA; Riboli E; Ricceri F; Rinaldi S; Rissanen H; Sawada N; Schaefer CA; Schenk JM; Stanczyk FZ; Stampfer M; Stattin P; Stenman UH; Tjønneland A; Trichopoulou A; Thompson IM; Tsugane S; Vatten L; Whittemore AS; Ziegler RG; Allen NE; Key TJ; Travis RC
PLoS One; 2017; 12(12):e0187741. PubMed ID: 29281666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
